Theralase Technologies (TSXV:TLT) Market Cap : C$51.01 Mil (As of Apr. 14, 2025)

View and export this data going back to 1996. Start your Free Trial

What is Theralase Technologies Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Theralase Technologies's share price for the quarter that ended in Dec. 2024 was C$0.265. Theralase Technologies's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 247.78 Mil. Therefore, Theralase Technologies's market cap for the quarter that ended in Dec. 2024 was C$65.66 Mil.

Theralase Technologies's quarterly market cap declined from Jun. 2024 (C$50.25 Mil) to Sep. 2024 (C$41.74 Mil) but then increased from Sep. 2024 (C$41.74 Mil) to Dec. 2024 (C$65.66 Mil).

Theralase Technologies's annual market cap declined from Dec. 2022 (C$69.28 Mil) to Dec. 2023 (C$39.98 Mil) but then increased from Dec. 2023 (C$39.98 Mil) to Dec. 2024 (C$65.66 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Theralase Technologies's Enterprise Value for Today is C$51.03 Mil.

Theralase Technologies Market Cap Historical Data

The historical data trend for Theralase Technologies's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theralase Technologies Market Cap Chart

Theralase Technologies Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Market Cap

Get a 7-Day Free Trial

38.81

76.60

69.28

39.98

65.66

Theralase Technologies Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Market Cap	Get a 7-Day Free Trial															39.98	37.70	50.25	41.74	65.66

Competitive Comparison of Theralase Technologies's Market Cap

For the Medical Devices subindustry, Theralase Technologies's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Theralase Technologies's Market Cap Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Theralase Technologies's Market Cap distribution charts can be found below:

* The bar in red indicates where Theralase Technologies's Market Cap falls into.

Save Embed

;

Save Embed

;

Theralase Technologies Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Theralase Technologies's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )	=	Share Price (A: Dec. 2024 )	*	Shares Outstanding (EOP) (A: Dec. 2024 )
	=	C$0.265	*	247.780
	=	C$65.66

Theralase Technologies's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )	=	Share Price (Q: Dec. 2024 )	*	Shares Outstanding (EOP) (Q: Dec. 2024 )
	=	C$0.265	*	247.780
	=	C$65.66

Theralase Technologies (TSXV:TLT) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Theralase Technologies Market Cap Related Terms

Thank you for viewing the detailed overview of Theralase Technologies's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Theralase Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Theralase Technologies Inc (TSXV:TLT) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

TLTFF:USA TTX:Germany

Address

41 Hollinger Road, Toronto, ON, CAN, M4B 3G4

Website

https://www.theralase.com

Theralase Technologies Inc is a clinical-stage pharmaceutical company. It is dedicated to the research and development of light-activated Photo Dynamic Compounds, their associated drug formulations, and technology platforms intended to safely and effectively; treat various cancers, bacteria, and viruses. The Cool Laser Technology division designs, develops, manufactures, and markets proprietary super-pulsed laser technology indicated and cleared by Health Canada and the FDA for the healing of chronic knee pain and when used off-label for healing numerous nerve, muscle, and joint conditions. The ACT division conducts preclinical and clinical research and development for PDCs, in the treatment of cancer, with assistance from the CLT division to develop medical lasers to activate them.

Executives

Matthew Thomas Perraton	Director
Roger John Dumoulin-white	10% Security Holder, Director, Senior Officer
Kristina Maria Hachey	Senior Officer
Arkady Mandel	Senior Officer
Guy John Anderson	Director
Shawn Shirazi	Senior Officer